Physician profile
Frederick White
NPI 1821062548
$2,751.37
in general payments reported to CMS, 2019-2025
21 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $323 · 2021: $415 · 2022: $396 · 2023: $582 · 2024: $463 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $923.48 | 2019-2025 | Lifevest |
| Pfizer INC. | $425.22 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $239.80 | 2021-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $195.82 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.01 | 2019-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $114.04 | 2023-2024 | Inpefa |
| Amgen INC. | $106.84 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $106.75 | 2019-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $85.97 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $83.60 | 2020-2023 | Farxiga |
| Scpharmaceuticals INC. | $78.87 | 2025 | |
| Atricure, INC. | $66.53 | 2019 | |
| Boston Scientific Corporation | $44.18 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Cds - Mct/Cem Monitoring |
| Kestra Medical Technology Services, INC. | $40.89 | 2024-2025 | Assure Wcd |
| Preventice Services, LLC | $27.26 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $24.21 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bayer Healthcare Pharmaceuticals INC. | $23.28 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.43 | 2024 | |
| Philips North America LLC | $14.07 | 2025 | Mcot |
| Gilead Sciences, INC. | $12.31 | 2019 | |
| Bardy Diagnostics, INC. | $1.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.